US IPO Weekly Recap: Preclinical biotech Nkarta pops 166% in a 5 IPO week

Three biotechs, two Chinese issuers, and one SPAC went public this past week, led by preclinical oncology biotech Nkarta (NKTX), which popped 166% in the best first-day return for a $10+ million IPO …
( read original story …)